Patient-Friendly Explanation
Dapagliflozin is a diabetes medication that helps your body remove excess sugar through urine. This also removes some calories and fluid, so many people lose a modest amount of weight while taking it. It is prescribed mainly for type 2 diabetes, heart failure, and kidney disease, not as a standalone weight-loss drug.
Clinical Definition
Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that blocks glucose reabsorption in the proximal renal tubule, promoting glycosuria and calorie loss. It produces modest, sustained weight reduction (typically 2-3 kg) alongside benefits for heart failure and chronic kidney disease. Weight loss is a secondary effect and dose-dependent; it is not licensed as a primary anti-obesity agent.
Why It Matters
Some medications prescribed for related conditions also support modest weight loss, and understanding these effects helps you and your doctor choose the right therapy. At NuLifeCare Singapore we consider your full health picture when planning medically supervised weight management.